CacheBy
Thermo Fisher Scientific Sclerostin Monoclonal Antibody (5D8D2D4)
원본

Thermo Fisher Scientific Sclerostin Monoclonal Antibody (5D8D2D4)

상품 한눈에 보기

인간 SOST/Sclerostin 단백질을 인식하는 단클론 항체로, ELISA에 적합합니다. 방부제가 포함되지 않아 오염 방지를 위해 sodium azide 첨가를 권장합니다. 단백질 A로 정제된 액상 형태이며, 단기 4°C, 장기 -20°C 보관이 가능합니다.

판매단위
pk
카탈로그 보기

카탈로그

1개 옵션
회원가입 없이 바로 구매하세요
가입하지 않아도 비회원가로 구매하실 수 있습니다.
마지막 업데이트 2025. 08. 03. 오후 08:39
Thermo Fisher Scientific MA529815 Sclerostin Monoclonal Antibody (5D8D2D4) 100 ul pk판매 단위 pk ·
재고 확인 필요
424,300원VAT 포함 466,730원

Thermo Fisher Scientific · Thermo Fisher Scientific Sclerostin Monoclonal Antibody (5D8D2D4)

Applications

ELISA (ELISA)

  • Tested Dilution: 1:1,000–1:2,000

Product Specifications

항목 내용
Species Reactivity Human
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Clone 5D8D2D4
Immunogen Recombinant Human SOST protein (Gln24–Tyr213)
Conjugate Unconjugated
Form Liquid
Concentration 1.18 mg/mL
Purification Protein A
Storage Buffer PBS
Contains No preservative
Storage Conditions Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Shipping Conditions Ambient (domestic); Wet ice (international)
RRID AB_2785636

Product Specific Information

This product is preservative-free. It is recommended to add sodium azide to avoid contamination (final concentration 0.05%–0.1%).
This antibody has specificity for Human SOST/Sclerostin.


Target Information

Sclerostin, a glycoprotein predominantly secreted by osteocytes, belongs to the Cerberus/DAN family of BMP antagonists and functions as an endogenous regulator of the canonical Wnt signaling pathway and bone homeostasis.
Although mainly expressed by osteocytes, it is also found in bone, bone marrow, cartilage, kidney, and liver, and is produced by hypertrophic chondrocytes and cementocytes.
Sclerostin regulates the Wnt/β-catenin signaling pathway by forming inhibitory complexes with LRP5 and LRP6, and interacts with LRP4 to facilitate inhibition of Wnt signaling.
It can promote osteoclast activity by increasing osteocyte expression of RANKL.
Mutations leading to decreased sclerostin levels cause bone dysplasia disorders such as sclerosteosis and van Buchem disease (VBD), characterized by progressive bone overgrowth and hypermineralization.


For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.

Thermo Fisher Scientific 상품 둘러보기

전체보기

문의

0

아직 등록된 문의가 없어요.